Search Results - "Duris, Tibor"
-
1
Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With ST-Segment Elevation Myocardial Infarction Also Treated With Clopidogrel
Published in Journal of the American College of Cardiology (12-06-2007)“…Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With ST-Segment Elevation Myocardial Infarction Also Treated With Clopidogrel Marc…”
Get full text
Journal Article -
2
Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial
Published in European heart journal. Cardiovascular pharmacotherapy (01-07-2020)“…Abstract Aims Non-vitamin K antagonist oral anticoagulants represent a new option for prevention of embolic events in patients with atrial fibrillation (AF)…”
Get full text
Journal Article -
3
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
Published in Journal of the American Heart Association (19-03-2019)“…Background There are limited data on how the combination of diabetes mellitus ( DM ) and chronic kidney disease ( CKD ) affects cardiovascular outcomes as well…”
Get full text
Journal Article -
4
Etiology and Risk Factors of 180 Cases of Native Valve Endocarditis
Published in Diagnostic microbiology and infectious disease (01-07-1998)Get full text
Journal Article -
5
QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation
Published in American journal of cardiovascular drugs : drugs, devices, and other interventions (01-06-2011)“…Background and Objective: AZD1305 is an investigational antiarrhythmic agent that prolongs refractoriness through combined potassium and sodium channel…”
Get full text
Journal Article -
6
Abstract 16587: Edoxaban Associated With Fewer Serious Adverse Events and Lower Mortality Than Warfarin, Regardless of Burden of Comorbidities: Insights From the ENGAGE AF-TIMI 48 Trial
Published in Circulation (New York, N.Y.) (11-11-2016)“…BackgroundAtrial fibrillation (AF) is more frequent in elderly pts and those with underlying cardiac and other comorbidities. The multicenter ENGAGE AF-TIMI 48…”
Get full text
Journal Article -
7
QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation: A Double-Blind, Randomized, Placebo-Controlled Trial
Published in American journal of cardiovascular drugs : drugs, devices, and other interventions (01-01-2011)“…Background and Objective AZD1305 is an investigational antiarrhythmic agent that prolongs refractoriness through combined potassium and sodium channel…”
Get full text
Journal Article -
8
Etiology and Risk Factors of 180 Cases of Native Valve Endocarditis: Report from a 5-Year National Prospective Survey in Slovak Republic
Published in Diagnostic microbiology and infectious disease (01-07-1998)“…Risk factors, e tiology, and outcome of 180 cases of infective endocarditis (IE) in the Slovak Republic for 5 years were prospectively studied in a national…”
Get full text
Journal Article